1,196 results on '"Pfister, Roman"'
Search Results
102. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation
103. Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review
104. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis
105. Guideline-directed medical treatment in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation
106. Three-dimensional compared to two-dimensional transesophageal echocardiography for diagnosis of infective endocarditis
107. Invasive Right Ventricular to Pulmonary Artery Coupling in Patients Undergoing Transcatheter Edge-to-Edge Tricuspid Valve Repair
108. Plasma vitamin C and risk of hospitalisation with diagnosis of atrial fibrillation in men and women in EPIC-Norfolk prospective study
109. Cardiac Manifestations in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Single-Center Study
110. Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018
111. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology—part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
112. Therapie der sekundären Mitralklappeninsuffizienz – Strategien eines interuniversitären Verbundes
113. Prognostic Performance of the Surgical TRI-SCORE Risk Score in Patients Undergoing Transcatheter Tricuspid Valve Treatment
114. TCT-532 Systolic Pulmonary Artery Derived From Echocardiography Is Not a Reliable Parameter in the Right Ventricular–Pulmonary Arterial Coupling in Patients Undergoing Transcatheter Tricuspid Valve Annuloplasty
115. Deep sedation vs. general anesthesia for transcatheter tricuspid valve repair
116. Sekundäre AV-Klappeninsuffizienzen – Stellenwert der interventionellen Therapie
117. Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients
118. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging
119. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective
120. Diagnostische Wertigkeit des Linksschenkelblocks bei Patienten mit akutem Myokardinfarkt: Eine prospektive Analyse
121. Imaging modalities in early cardiac transthyretin amyloidosis: who is first?
122. Left atrial volume index and outcome after transcatheter edge‐to‐edge valve repair for secondary mitral regurgitation
123. Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair
124. Risk Scores for Mortality Prediction After Transcatheter Mitral Valve Repair
125. A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair
126. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC—Norfolk study
127. Analysis of tricuspid annulus dimensions and RCA-proximity with artificial intelligence-based software for procedural planning of percutaneous tricuspid annuloplasty
128. Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair
129. Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation
130. A staging classification of right heart remodelling for patients transcatheter-to mitral valve
131. Treatment of Secondary Mitral Regurgitation - Strategies of a University Network
132. Deep sedation vs. general anesthesia for transcatheter tricuspid valve repair
133. Prevalence of left ventricular thrombus formation after mitral valve edge-to-edge repair
134. Secondary AV Valve Insufficiency - Importance of Interventional Therapy
135. Prognostic Performance of the Surgical TRI-SCORE Risk Score in Patients Undergoing Transcatheter Tricuspid Valve Treatment
136. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
137. Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitation
138. Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results
139. Solving the Pulmonary Hypertension Paradox in Patients With Severe Tricuspid Regurgitation by Employing Artificial Intelligence
140. Recurrent Mitral Regurgitation After MitraClip: Predictive Factors, Morphology, and Clinical Implication
141. A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
142. Repeated apnea-induced contraction of the spleen in cyclists does not enhance performance in a subsequent time-trial
143. Challenges in the performance of real-life studies in older patients: focus on long-term care facilities
144. Recurrent Mitral Regurgitation After MitraClip: Predictive Factors, Morphology, and Clinical Implication
145. Solving the Pulmonary Hypertension Paradox in Patients With Severe Tricuspid Regurgitation by Employing Artificial Intelligence
146. Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair: Tricuspid regurgitation after MitraClip procedure
147. Supplement to: Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
148. Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition–Norfolk prospective study
149. Real-World Anticoagulatory Treatment After Transcatheter Aortic Valve Replacement: A Retrospective, Observational Study on 4,800 Patients
150. TCT-105 Impact of Pulmonary Hypertension Differentiation on the Outcome of Patients Undergoing MitraClip Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.